We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Chinese API Manufacturer Cited for Quality Shortcomings
Chinese API Manufacturer Cited for Quality Shortcomings
The FDA issued a warning letter to Zhuhai United Laboratories, an active pharmaceutical ingredient firm based in Zhuhai, China, taking the facility to task for failure to investigate out-of-specification results and to correct critical CGMP deviations.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor